Qihengxing passed the national "High-tech Enterprise" certification

Beijing Qihengxing Biotechnology Co., Ltd. was established in 2018. It is a national high-tech enterprise with many invention patents. Relying on core technology platforms such as enzyme engineering platform, PCR/qPCR system platform, nucleic acid extraction platform, NGS platform with independent intellectual property rights, the company has developed many high-quality products in multiple application directions such as molecular biology, NGS application, and synthetic biology, and has built a